Bristol-Myers To Buy Orbital Therapeutics For $1.5 Billion Cash Deal

Benzinga 2025-10-10

Views 13

Bristol-Myers Squibb will buy Orbital Therapeutics for $1.5B, adding experimental CAR T-cell treatments for autoimmune diseases. The deal aims to expand and streamline Bristol’s cell therapy portfolio.

Share This Video


Download

  
Report form